Radiosurgery Treatment for Spasticity Associated With Stroke, SCI & Cerebral Palsy
Launched by OHIO STATE UNIVERSITY · Sep 30, 2023
Trial Information
Current as of June 27, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new treatment for people who have tight muscles, a condition known as spasticity, which can happen after a stroke, in those with spastic cerebral palsy, or from spinal cord injuries. The treatment being tested is called "stereotactic radiosurgery dorsal rhizotomy." It uses focused beams of radiation to target specific nerves in the back to help relax the muscles. Participants in the study will be randomly divided into two groups: one will receive the actual treatment, while the other will receive a "sham" treatment that does not have any active effect. This design helps ensure the study's results are accurate.
To be eligible for the trial, participants must be over 16 years old and have spasticity that hasn’t improved with other treatments. They should be able to lie down comfortably during the procedure and the target nerves must be visible in imaging tests. Women of child-bearing age will need to take a pregnancy test before joining the study. After receiving their treatment, participants will be monitored to see if their muscle stiffness improves and to check for any side effects. Additionally, those who receive the sham treatment will have the chance to get the real treatment after six months.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Chronic spasticity refractory to medical management or in a patient who cannot receive appropriate medical management mediated by one or more spinal nerve roots
- • Age \> 16 (if under 18, patients parents must sign consent).
- Exclusion Criteria:
- • Inability to lie supine for simulation \& treatment
- • Inability to visualize the target nerve on either CT or MRI imaging
- • Patients with confirmed pregnancy (all women of child-bearing age with intact uterus \& ovaries will be required to undergo a pregnancy test prior to simulation)
About Ohio State University
The Ohio State University (OSU) is a leading research institution dedicated to advancing health and science through innovative clinical trials. With a commitment to improving patient care and outcomes, OSU leverages its extensive resources, interdisciplinary collaboration, and expertise in diverse medical fields. The university fosters an environment of rigorous scientific inquiry, ensuring that clinical trials are conducted with the highest ethical standards and adherence to regulatory guidelines. Through its Clinical Trials Office, OSU aims to translate groundbreaking research into practical applications, benefiting both local and global communities.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Columbus, Ohio, United States
Milano, , Italy
Patients applied
Trial Officials
Evan Thomas, MD/PhD
Principal Investigator
Ohio State University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported